CIK 0001719406
- Non-accelerated filer
- Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822844431
- Phone
- +1 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 50,000 shares at $1.17 ($58,500)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 30,000 shares at $1.10 ($33,000)
- 4/A Open-market buy CHIEF FINANCIAL OFFICER bought 16,337 shares at an average $1.11 ($18,215)
- 4 Open-market sale Director sold 400,000 shares at $1.00 ($400,000)
- 4 Open-market sale 10% owner sold 22,171 shares at an average $1.50 ($33,352)
- 4 Open-market buy Director bought 11,750 shares at an average $1.25 ($14,663)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 16,337 shares at an average $1.11 ($18,215)
- 4/A Open-market buy Director bought 500,000 shares at an average $1.03 ($514,905)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 500,000 shares at an average $1.03 ($514,905)
- 4 Open-market sale 10% owner sold 166,737 shares at an average $1.03 ($171,138)
- 4 Open-market sale 10% owner sold 49,200 shares at $1.01 ($49,510)
- 4 Open-market sale 10% owner sold 784,063 shares at $1.01 ($791,433)
- 3 Insider Initial Statement of Ownership
- 4 Gift 10% owner gave 2,000,000 shares (gift)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 445,712 shares at an average $0.68 ($303,910)
- 4/A Open-market buy Chief Scientist bought 100,000 shares at $0.58 ($58,000)
Page 2 of 5 · 84 filings